Subject Expert Committee recommends EUA for BE’s Covid jab Corbevax for 12-18 years age group
Summary : The expert panel of India’s central drug authority on Monday recommended granting restricted Emergency Use Authorisation (EUA) to Biological E’s…
Summary : The expert panel of India’s central drug authority on Monday recommended granting restricted Emergency Use Authorisation (EUA) to Biological E’s…
Summary – The outbreak of Covid-19 pandemic has made it necessary to regulate the manufacture, stock, sale or distribution of new drug…
Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
Summary : If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at…
PF-07321332 & Ritonavir (Paxlovid): Pfizer Gets CDSCO Panel Nod To Study For COVID Treatment. The Central Drugs Standard Control Organisation(CDSCO) under Directorate General…
HIGHLIGHTS: Spain’s top research institution struck a licensing deal that paves the way for its COVID-19 antibody test to be produced more…
SYNOPSIS: Takeda announced that U.S. FDA Approved LIVTENCITY (Maribavir) as the First and Only Treatment for People Ages 12 or older and…
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of…
Pune-based Serum Institute of India (SII) is expected to supply 25 million doses to the Covax facility till December, as it looks…